Pre-gestational diabetes in a young woman with a pathogenic INSR missense mutation, p.(Met1180Lys)

Heterozygous insulin receptor (INSR) mutations cause type A insulin resistance (IR), associated with a phenotype of IR; hyperandrogenism, oligomenorrhoea and acanthosis nigricans in the absence of obesity or lipoatrophy. The phenotype is variable, ranging from neonatal hyperinsulinaemic hypoglycaemi...

Full description

Saved in:
Bibliographic Details
Main Authors: Emma L Prehn, Mairéad Crowley, David Fennell, Brendan T Kinsley, Kevin Colclough, Maria M Byrne
Format: Article
Language:English
Published: Bioscientifica 2025-02-01
Series:Endocrinology, Diabetes & Metabolism Case Reports
Subjects:
Online Access:https://edm.bioscientifica.com/view/journals/edm/2025/1/EDM-24-0087.xml
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860042913284096
author Emma L Prehn
Mairéad Crowley
David Fennell
Brendan T Kinsley
Kevin Colclough
Maria M Byrne
author_facet Emma L Prehn
Mairéad Crowley
David Fennell
Brendan T Kinsley
Kevin Colclough
Maria M Byrne
author_sort Emma L Prehn
collection DOAJ
description Heterozygous insulin receptor (INSR) mutations cause type A insulin resistance (IR), associated with a phenotype of IR; hyperandrogenism, oligomenorrhoea and acanthosis nigricans in the absence of obesity or lipoatrophy. The phenotype is variable, ranging from neonatal hyperinsulinaemic hypoglycaemia to fasting or post-prandial hypoglycaemia in adults to diabetes. We report a 29-year-old woman presenting at 13 weeks gestation in her second pregnancy. Diabetes was diagnosed at 13-years-old following presentation with lethargy and polyuria and she was treated with metformin 500 mg po bd. She also had polycystic ovarian syndrome, hypothyroidism and epilepsy. Metformin was changed to insulin with good glycaemic control throughout pregnancy. She delivered a 3.95 kg male infant at 39 weeks gestation without neonatal hypoglycaemia. At 18 months post-partum, her body mass index was 26.3 kg/m2, with no evidence of acanthosis nigricans or features of lipodystrophy. As her sister was also diagnosed with diabetes at 13-years-old, next-generation sequencing was performed for known maturity onset diabetes of the young (MODY) genes and a p.(Met1180Lys) mutation in the INSR gene was detected. She reported nocturnal hypoglycaemia and a 5-h oral glucose tolerance test revealed post-prandial hyperinsulinaemic hypoglycaemia at 210 min. Her subsequent pregnancy was spontaneously treated with metformin 500 mg po od from 8 to 25 weeks gestation and discontinued due to intrauterine growth restriction. She delivered a 1.8 kg female infant at 34 plus 3 weeks gestation (25th centile) via elective caesarean section. The infant had transient neonatal hypoglycaemia for two days. Post-partum, she remains diet controlled, with a haemoglobin A1c of 32 mmol/mol. This case highlights the importance of genetic testing to establish optimal diabetes treatment.
format Article
id doaj-art-57bd67c2854b4921b6d7ea1dfd6c2876
institution Kabale University
issn 2052-0573
language English
publishDate 2025-02-01
publisher Bioscientifica
record_format Article
series Endocrinology, Diabetes & Metabolism Case Reports
spelling doaj-art-57bd67c2854b4921b6d7ea1dfd6c28762025-02-10T16:57:08ZengBioscientificaEndocrinology, Diabetes & Metabolism Case Reports2052-05732025-02-012025110.1530/EDM-24-00871Pre-gestational diabetes in a young woman with a pathogenic INSR missense mutation, p.(Met1180Lys)Emma L Prehn0Mairéad Crowley1David Fennell2Brendan T Kinsley3Kevin Colclough4Maria M Byrne5Department of Diabetes and Endocrinology, Mater Misericordiae University Hospital, Dublin 7, IrelandDepartment of Diabetes and Endocrinology, Mater Misericordiae University Hospital, Dublin 7, IrelandDepartment of Diabetes and Endocrinology, Mater Misericordiae University Hospital, Dublin 7, IrelandDepartment of Diabetes and Endocrinology, Mater Misericordiae University Hospital, Dublin 7, IrelandDepartment of Molecular Genetics, Royal Devon and Exeter NHS Foundation Trust, Exeter, UKDepartment of Diabetes and Endocrinology, Mater Misericordiae University Hospital, Dublin 7, IrelandHeterozygous insulin receptor (INSR) mutations cause type A insulin resistance (IR), associated with a phenotype of IR; hyperandrogenism, oligomenorrhoea and acanthosis nigricans in the absence of obesity or lipoatrophy. The phenotype is variable, ranging from neonatal hyperinsulinaemic hypoglycaemia to fasting or post-prandial hypoglycaemia in adults to diabetes. We report a 29-year-old woman presenting at 13 weeks gestation in her second pregnancy. Diabetes was diagnosed at 13-years-old following presentation with lethargy and polyuria and she was treated with metformin 500 mg po bd. She also had polycystic ovarian syndrome, hypothyroidism and epilepsy. Metformin was changed to insulin with good glycaemic control throughout pregnancy. She delivered a 3.95 kg male infant at 39 weeks gestation without neonatal hypoglycaemia. At 18 months post-partum, her body mass index was 26.3 kg/m2, with no evidence of acanthosis nigricans or features of lipodystrophy. As her sister was also diagnosed with diabetes at 13-years-old, next-generation sequencing was performed for known maturity onset diabetes of the young (MODY) genes and a p.(Met1180Lys) mutation in the INSR gene was detected. She reported nocturnal hypoglycaemia and a 5-h oral glucose tolerance test revealed post-prandial hyperinsulinaemic hypoglycaemia at 210 min. Her subsequent pregnancy was spontaneously treated with metformin 500 mg po od from 8 to 25 weeks gestation and discontinued due to intrauterine growth restriction. She delivered a 1.8 kg female infant at 34 plus 3 weeks gestation (25th centile) via elective caesarean section. The infant had transient neonatal hypoglycaemia for two days. Post-partum, she remains diet controlled, with a haemoglobin A1c of 32 mmol/mol. This case highlights the importance of genetic testing to establish optimal diabetes treatment.https://edm.bioscientifica.com/view/journals/edm/2025/1/EDM-24-0087.xmldiabetesmetabolisminsr mutationpregnancyhypoglycaemia
spellingShingle Emma L Prehn
Mairéad Crowley
David Fennell
Brendan T Kinsley
Kevin Colclough
Maria M Byrne
Pre-gestational diabetes in a young woman with a pathogenic INSR missense mutation, p.(Met1180Lys)
Endocrinology, Diabetes & Metabolism Case Reports
diabetes
metabolism
insr mutation
pregnancy
hypoglycaemia
title Pre-gestational diabetes in a young woman with a pathogenic INSR missense mutation, p.(Met1180Lys)
title_full Pre-gestational diabetes in a young woman with a pathogenic INSR missense mutation, p.(Met1180Lys)
title_fullStr Pre-gestational diabetes in a young woman with a pathogenic INSR missense mutation, p.(Met1180Lys)
title_full_unstemmed Pre-gestational diabetes in a young woman with a pathogenic INSR missense mutation, p.(Met1180Lys)
title_short Pre-gestational diabetes in a young woman with a pathogenic INSR missense mutation, p.(Met1180Lys)
title_sort pre gestational diabetes in a young woman with a pathogenic insr missense mutation p met1180lys
topic diabetes
metabolism
insr mutation
pregnancy
hypoglycaemia
url https://edm.bioscientifica.com/view/journals/edm/2025/1/EDM-24-0087.xml
work_keys_str_mv AT emmalprehn pregestationaldiabetesinayoungwomanwithapathogenicinsrmissensemutationpmet1180lys
AT maireadcrowley pregestationaldiabetesinayoungwomanwithapathogenicinsrmissensemutationpmet1180lys
AT davidfennell pregestationaldiabetesinayoungwomanwithapathogenicinsrmissensemutationpmet1180lys
AT brendantkinsley pregestationaldiabetesinayoungwomanwithapathogenicinsrmissensemutationpmet1180lys
AT kevincolclough pregestationaldiabetesinayoungwomanwithapathogenicinsrmissensemutationpmet1180lys
AT mariambyrne pregestationaldiabetesinayoungwomanwithapathogenicinsrmissensemutationpmet1180lys